Want to see AU:ARX full AI Analyst Report?

Aroa Biosurgery Ltd (ARX) Price & Analysis

62 Followers

ARX Stock Chart & Stats

AU$0.53

AU$0.00(0.00%)

At close: Jan 09 4:00 PM EST

AU$0.53

AU$0.00(0.00%)

Day’s Range― - ―

52-Week RangeAU$0.50 - AU$0.80

Previous CloseN/A

Volume195.72K

Average Volume (3M)302.12K

Market Cap

AU$205.81M

Enterprise ValueAU$214.05M

Total Cash (Recent Filing)AU$22.60M

Total Debt (Recent Filing)AU$5.31M

Price to Earnings (P/E)59.5

Beta0.59

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding345,902,650

10 Day Avg. Volume330,836

30 Day Avg. Volume302,123

Financial Highlights & Ratios

PEG Ratio-0.23

Price to Book (P/B)2.48

Price to Sales (P/S)2.23

P/FCF Ratio24.50

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

AU$1.08

Price Target Upside103.14% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering3

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Multi-year Revenue GrowthSustained top-line expansion (2021–2026) demonstrates durable commercial traction for Aroa’s ovine ECM products, reflecting broader clinical adoption and stronger distribution. This scale supports fixed-cost absorption, product development funding, and long-term revenue runway independent of short-term cycles.

Improved Cash GenerationThe conversion to positive operating and free cash flow in 2026 provides durable financial flexibility: it funds R&D and commercial expansion, lowers reliance on external capital, and gives higher quality to reported earnings (free cash flow ~0.89x net income), underpinning sustainable investment capacity.

Conservative Balance SheetLow leverage and substantial equity provide a structural buffer to support growth initiatives and absorb shocks. This conservative capital structure allows management to pursue commercial scaling or M&A without immediate funding pressure and reduces insolvency risk during industry cyclicality.

Bears Say

Earnings Consistency RiskPrior multi-year losses mean recent profitability is an inflection rather than an established run-rate. Durable confidence requires reproducible earnings across cycles; historical losses imply operational or adoption risks that could re-emerge if revenue growth slows or one-off benefits fade.

Thin Net MarginVery high gross margins but modest net margins indicate substantial operating or SG&A load relative to sales. Until operating leverage consistently converts gross margins into stronger net margins, profitability remains vulnerable to increased commercial spending or pricing pressure in key markets.

Cash Flow VolatilityThe recent swing to positive cash flow follows years of large cash deficits, highlighting volatility in cash conversion. Such variability makes internal funding of growth uncertain and increases exposure to external financing risk if positive cash generation is not sustained over multiple reporting periods.

Aroa Biosurgery Ltd News

Aroa Biosurgery Lodges Appendix 4G, Reaffirming ASX Governance Compliance

Aroa Biosurgery Ltd ( ($AU:ARX) ) has provided an update. Aroa Biosurgery Limited is a medical technology company...

2d ago

ARX

Aroa Biosurgery Sets Out 2026 Performance and Key Dates in Annual Report

Aroa Biosurgery Ltd ( ($AU:ARX) ) just unveiled an announcement. Aroa Biosurgery has released its annual report for...

2d ago

ARX

Aroa Biosurgery director trims indirect shareholding in on-market sale

Aroa Biosurgery Ltd ( ($AU:ARX) ) just unveiled an announcement. Aroa Biosurgery has disclosed a change in the...

3d ago

ARX

Aroa Biosurgery Sets AGM Date as Long-Serving Director Plans Retirement

Aroa Biosurgery Ltd ( ($AU:ARX) ) just unveiled an update. Aroa Biosurgery Ltd has scheduled its next Annual...

8d ago

ARX

Aroa Biosurgery Corrects Typo in FY26 Results Investor Presentation

Aroa Biosurgery Ltd ( ($AU:ARX) ) just unveiled an announcement. Aroa Biosurgery has issued a correction to its...

1M ago

ARX

Aroa Biosurgery Lifts FY26 Revenue 23% and Targets Further Growth With Higher FY27 Investment

Aroa Biosurgery Ltd ( ($AU:ARX) ) has provided an announcement. Aroa Biosurgery reported FY26 total revenue of NZ$103.9...

1M ago

ARX

Aroa Biosurgery Beats FY26 Guidance on Strong Myriad Sales and Margin Lift

Aroa Biosurgery Ltd ( ($AU:ARX) ) has shared an update. Aroa Biosurgery reported preliminary unaudited FY26 results showing...

2M ago

ARX

Aroa Biosurgery Seeks ASX Quotation for New Share Issue

Aroa Biosurgery Ltd ( ($AU:ARX) ) has shared an update. Aroa Biosurgery Ltd has applied to the ASX...

3M ago

ARX

Aroa Biosurgery Flags Lapse and Expiry of Equity Incentives, Trimming Potential Dilution

Aroa Biosurgery Ltd ( ($AU:ARX) ) has issued an announcement. Aroa Biosurgery has notified the market of the...

3M ago

ARX

Aroa Biosurgery’s Symphony Trial Hits Key Endpoint in Diabetic Foot Ulcers

Aroa Biosurgery Ltd ( ($AU:ARX) ) has issued an update. Aroa Biosurgery has completed a multi-centre randomised controlled...

3M ago

ARX

ARX FAQ

What was Aroa Biosurgery Ltd’s price range in the past 12 months?

Aroa Biosurgery Ltd lowest share price was AU$0.49 and its highest was AU$0.80 in the past 12 months.

What is Aroa Biosurgery Ltd’s market cap?

Aroa Biosurgery Ltd’s market cap is AU$205.81M.

When is Aroa Biosurgery Ltd’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Aroa Biosurgery Ltd’s earnings last quarter?

Currently, no data Available

Is Aroa Biosurgery Ltd overvalued?

According to Wall Street analysts Aroa Biosurgery Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Aroa Biosurgery Ltd pay dividends?

Aroa Biosurgery Ltd does not currently pay dividends.

What is Aroa Biosurgery Ltd’s EPS estimate?

Aroa Biosurgery Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aroa Biosurgery Ltd have?

Aroa Biosurgery Ltd has 345,902,650 shares outstanding.

What happened to Aroa Biosurgery Ltd’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Aroa Biosurgery Ltd?

Currently, no hedge funds are holding shares in AU:ARX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Aroa Biosurgery Ltd Stock Smart Score

Neutral

Fundamentals

Return on Equity

4.20%

Trailing 12-Months

Asset Growth

1.55%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Aroa Biosurgery Ltd

Aroa Biosurgery Limited operates as a regenerative medicine company dedicated to the development, production, and global distribution of medical solutions for wound and tissue repair. The firm innovatively utilizes extracellular matrix (ECM) technology, with its market presence spanning the United States and international territories. Its product line encompasses Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold, tailored for managing both acute and chronic wounds. Additionally, the company offers Myriad Matrix, an engineered ECM device designed for soft tissue repair, reinforcement, and complex wound treatment, along with Myriad Morcells, a powdered version of Myriad Matrix serving similar soft tissue and complex wound applications. Rounding out its offerings are Reinforced Bioscaffolds, a specialized surgical product employed in ventral hernia repair and abdominal wall reconstruction. Founded in 2007, Aroa Biosurgery Limited is headquartered in Auckland, New Zealand.

Aroa Biosurgery Ltd (ARX) Earnings & Revenues

Historic Earnings Reports

ARX Stock 12 Month Forecast

Average Price Target

AU$1.08

▲(103.14% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"AU$2","-1":"-AU$1","-0.25":"-AU$0.25","0.5":"AU$0.5","1.25":"AU$1.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$1.35</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.0766666666666669,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$1.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.79,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$0.79</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.25,0.5,1.25,2],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.595,0.6530769230769231,0.7111538461538461,0.7692307692307693,0.8273076923076923,0.8853846153846154,0.9434615384615386,1.0015384615384617,1.0596153846153846,1.1176923076923078,1.175769230769231,1.2338461538461538,1.291923076923077,{"y":1.35,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.595,0.632051282051282,0.6691025641025641,0.7061538461538461,0.7432051282051282,0.7802564102564102,0.8173076923076924,0.8543589743589745,0.8914102564102565,0.9284615384615386,0.9655128205128206,1.0025641025641028,1.0396153846153848,{"y":1.0766666666666669,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.595,0.61,0.625,0.64,0.655,0.67,0.685,0.7,0.715,0.73,0.745,0.76,0.775,{"y":0.79,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.56,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.64,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.64,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.68,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.78,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.66,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.73,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.64,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.66,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.59,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.62,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.655,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.595,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >